Asian News International on MSN1d
Breakthrough in Liver Failure Treatment: Bengaluru Scientists & Doctors Develop Game-Changing EBDLR System
A Lifesaving Innovation in the Fight Against Acute Liver Failure A revolutionary medical breakthrough is offering new hope in ...
Yaqrit prepares phase 3 for ammonia scavenger in hepatic encephalopathy
Acute and chronic treatment for hepatic encephalopathy acquired from Mallinckrodt Pharmaceuticals in September 2024Extended pre-clinical, ...
The Taipei Times1d
Fatty liver could protect against hepatitis B: study
Research conducted by a local hospital has found that hepatitis B patients with a simple fatty liver have a lower mortality ...
The Lancet18h
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...
Verywell Health on MSN1h
What Happens to Your Body When You Drink Beet Juice Daily
Beet juice is a nutritious beverage with many health benefits. This article reviews the benefits, safety, and use of beet ...
6 Things to Do When You Wake Up If You Have Chronic Inflammation, According to Dietitians
Common symptoms of chronic inflammation include fatigue, joint or muscle pain, long-lasting digestive issues, brain fog or ...
The Punch on MSN6d
Understanding gallbladder issues in sickle cell patients
High bilirubin levels increase the risk of developing bilirubin gallstones—a type of gallstone more prevalent in Sickle Cell ...
Medscape4d
Feeding the Child with Liver Disease
A thorough nutrition assessment of a child with liver disease is essential ... but provides little guidance for acute management. Dietary Assessment A thorough diet history is essential and ...
TMCnet3d
Travere Therapeutics to Submit sNDA for FILSPARI® (sparsentan) in FSGS
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25. If approved, FILSPARI could be the first and only approv ...
Genfit’s (GNFT) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Genfit (NASDAQ:GNFT – Free Report) in a report published on Friday,Benzinga reports. HC Wainwright currently has a $13.00 price target on the stock ...
TMCnet1d
Agios' Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint
All patients in both treatment arms completed the 20-week double-blind period of the study. In the 20-week double-blind period of the study, similar proportion of patients had adverse events (AEs) in ...
Travere Therapeutics, Inc.: Travere Therapeutics to Submit sNDA for FILSPARI (sparsentan) in FSGS
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated ...